Pharmaceutical

J&J’s sBLAs seek FDA approval of TREMFYA for paediatric conditions

J&J is seeking approval of TREMFYA for paediatric conditions with the submission of two sBLA to the US Food and Drug Administration.

Dec 3, 2024 - 06:00
J&J’s sBLAs seek FDA approval of TREMFYA for paediatric conditions
J&J is seeking approval of TREMFYA for paediatric conditions with the submission of two sBLA to the US Food and Drug Administration.
Read the original article

Tags:

Previous Article

You’re Addicted To Sugar: How Sugar Can Diminish Your Health

Next Article

Novartis and PTC Therapeutics link to develop Huntington’s therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Gene therapy death was caused by an unknown risk of the virus used, study suggests

Gene therapy death was caused by an unknown risk of the...

Sep 28, 2023

Investigators fault Lilly plant for manufacturing issues

Investigators fault Lilly plant for manufacturing issues

Jan 22, 2024

Merus gets grant for treatment of clec12a positive canc...

May 1, 2024